- Filed
- Mar 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | FY 2024 · Dec 31, 2024 | $130K |
| Capex | FY 2024 · Dec 31, 2023 | $19K |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 2.56M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$79M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $135.7M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $23.91M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $59.45M |
| Current Assets | FY 2024 · Dec 31, 2023 | $141.08M |
| Total Assets | FY 2024 · Dec 31, 2023 | $151.53M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$34.20 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$34.20 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $30.62M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $73.04M |
| Net Income | FY 2024 · Dec 31, 2023 | −$87.68M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$88.13M |
| Revenue | FY 2024 · Dec 31, 2023 | $6.19M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $103.9M |